Sensome today announced positive results from two studies of its Clotlid smart guidewire system for identifying blood clots. Outcomes highlighted Clotlid's ability to successfully identify "fresh" clot — thrombus rich in red blood cells (RBCs) — in peripheral artery disease (PAD) and differentiate it from other tissue encountered during PAD … [Read more...] about Sensome data supports clot-sensing guidewire
Cardiology
Vantis Vascular closes $10M Series B
Vantis Vascular announced today that it successfully closed a Series B-1 preferred financing round worth $10 million. San Jose, California-based Vantis' latest funding brings the company to $30 million raised to date. The company develops the CrossFast microcatheter guide extension system along with the CrossShock intravascular lithotripsy (IVL) … [Read more...] about Vantis Vascular closes $10M Series B
Second Heart Assist concludes mechanical circulatory support trial
Second Heart Assist announced today that it completed the third in a planned series of studies for its mechanical circulatory support device. Whisper, a catheter-based, minimally invasive device, utilizes a stent cage fitted with a motorized impeller. It aids in providing circulatory support throughout a patient’s body. The system is intended … [Read more...] about Second Heart Assist concludes mechanical circulatory support trial
Anteris Technologies launches IPO to support heart valve technology
Anteris Technologies today announced the launch of its initial public offering in the U.S. The company aims to raise funds through the IPO to advance the development of its DurAVR transcatheter heart valve technology. Anteris’ IPO consists of 14.8 million shares of common stock, with an additional 2.22 million shares available to underwriters … [Read more...] about Anteris Technologies launches IPO to support heart valve technology
Stereotaxis wins approval in China for magnetic ablation catheter
Stereotaxis (NYSE:STXS) announced today that its Magbot magnetic navigation ablation catheter received regulatory approval in China. This nod comes just weeks after the company won approval from China’s National Medical Products Administration for the Genesis robotic magnetic navigation (RNM) system. St. Louis, Missouri-based Stereotaxis aims to … [Read more...] about Stereotaxis wins approval in China for magnetic ablation catheter
FDA grants breakthrough nod to pulsed field ablation tech from Farapulse founder’s Field Medical
Field Medical announced today that it received FDA breakthrough device designation for its FieldForce pulsed field ablation (PFA) system. The FDA also accepted the technology into its Total Product Lifecycle Advisory Program (TAP). TAP provides early and frequent strategic engagement from the FDA, patients, providers and payers. It facilitates … [Read more...] about FDA grants breakthrough nod to pulsed field ablation tech from Farapulse founder’s Field Medical
Terumo launches R2P NaviCross peripheral support catheter in US
Terumo is further boosting its radial-to-peripheral portfolio with the U.S. launch of its R2P NaviCross peripheral support catheter. The Japanese medtech giant's Terumo Interventional Systems division designed the R2P NaviCross catheter for optimized performance in R2P procedures, which involve accessing the radial artery around the wrist in … [Read more...] about Terumo launches R2P NaviCross peripheral support catheter in US
First U.S. cases performed with Medtronic Affera ablation system
A hospital in Texas announced today that its electrophysiologists completed the first U.S. cases with the Medtronic (NYSE:MDT) Affera platform. EPs at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center performed the procedures with Affera. Dr. Andrea Natale and Dr. Amin Al-Ahmad conducted the first procedure on Nov. 7. A … [Read more...] about First U.S. cases performed with Medtronic Affera ablation system
FastWave Medical secures sixth patent for IVL portfolio
FastWave Medical today announced the sixth U.S. utility patent for its laser-based intravascular lithotripsy (IVL) technology for treating calcific artery disease. This is the fourth patent that Minneapolis-based FastWave Medical has secured from the U.S. Patent and Trademark Office this year. The company announced previous patents in May and … [Read more...] about FastWave Medical secures sixth patent for IVL portfolio
Medtronic Evolut Pro TAVR demonstrates positive outcomes in study
Medtronic (NYSE:MDT) this week shared new clinical data supporting its Evolut Pro/Pro+ transcatheter aortic valve replacement (TAVR) system. Findings included cusp overlap technique (COT) outcomes from the Optimize PRO clinical study and pooled analysis looking at Evolut Pro patients showing improvement in paravalvular leak (PVL) over time … [Read more...] about Medtronic Evolut Pro TAVR demonstrates positive outcomes in study
